Exam III Anti-fungal Drug Names Flashcards

(46 cards)

1
Q

Yeast

A

Candida SP.**

Pneumocystis jyrovecii

Cryptococcus neoformans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mold

A

Aspergillus SP.**

Mucor

Dermatophytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dimorphic

A

Blastomyces

Coccidiomycosis

Histoplasma

Sporotrichosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Allylamines

A

4 Fines

Terbinafine

Butenafine

Naftifine

AmorolFine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Allylamine MOA

A

Inhibit Squalene -> no ergosterol synthesis (reducing fungal cell membrane)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Allylamine Coverage

A

Tinea (Cosporis/Pedis/Cruris)

Onychomycosis (Terbinafine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Allylamine MISC facts

A

Terbinafine is the only one you can use for Onychomycosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Polyenes

A

Nystatin (PO/Topical/Susp)

Amphotericin B Deoxycholate (AmB-d) (IV)

Amphotericin B​ Lipid complex (ABLC)

Liposomal Amphotericin B (L-AmB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Polyenes MoA

A

Binds Ergosterol. Cell Leaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nystatin Coverage

A

Candida only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amphotericin B (and Derivs) Coverage

A

Most Candida spp. and Aspergillus spp.

Most Fungi except no Fusarium spp. and A. Terreus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amphotericin B ADRs/DDIs

A

Extremely nephrotoxic. Dose-Dependent decrease in GFR (monitor).

K, Mg, HCO3 wasting (electrolyte derangement)

Decreased EPO production. Avoid W/other nephrotoxic drugs

Acute Infusion RXN. (pre-medicate with APAP, or IBU, diphenhydramine +/- steroids, Rigors: meperidine)

Support with Fluids (Hydrate)

Thrombophlebitis (heparin), cardiac arrhythmias, and Rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amphotericin B DDIs worst to least.

A

AmB-d (base)

ABLC

(Less Nephrotoxic & Less infusion RXN)

L-AmB

(Less nephrotoxic & Less infusion RXN & better CNS penetration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Imidiazoles

A

Clotrimazole

Ketoconazole

Miconazole

Econazole

Mebendazole

Oxiconazole

Sertaconazole

Sulconazole

Thiabendazole

CloK ME MOST azole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ketoconazole (and other Imidazoles) MoA

A

Inhibit 14a-demethylase. No conversion of lanosterol to ergosterol. No CM synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ketoconazole Coverage

A

Andida spp., blastomycosis, histoplasmosis (high failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ketoconazole DDIs

A

CYP450/3A4 substrate ->CYP inhibition

Needs acidic gastric pH -> H2RA, PPI, antacid interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ketoconazole MISC

A

Poor distribution into CSF and eye

Contraindicated in patients w/ hepatic impairment

Excreted in Feces

Available in many forms

Half-life 8 Hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Triazoles

A

Fluconazole (PO/IV/S)

Voriconazole (PO/IV/Drops)

Isavuconazole (PO/IV)

Itraconazole (PO/IV/S)

Posaconazole (PO/IV/S)

F VIIP

20
Q

Triazole MoA

A

Inhibit 14-a demethylase. No conversion of lanosterol to ergosterol. No CM synthesis.

21
Q

Fluconazole& Itraconazole coverage

A

NO

C. Glabrata

C. Krusei

Aspergillus (Fluconazole only)

Fusarium

Scedosporium

Zygomycetes

22
Q

Fluconazole ADR/DDI

A

Minor CYP3A4 / Moderate CYP2C9 inhibitor

If CrCL <50 half the dose.

23
Q

Fluconazole MISC

A

Wide distribution

CNS Penetration

Halflife 30 hrs 98-125 in renal impairment

24
Q

Voriconazole coverage

A

NO

Scedosporim

Zygomycetes

25
Voriconazole ADR/DDI
NVD Liver dysfunction Visual abnormalities HA Substrate and inhibitor of CYP3A4/2C9/2C19 Reduced Bioavailability w/ high fat meals
26
Voriconazole Misc
Good CNS **_Monitor_** SCr Electrolytes LFTs (Nephrotoxic) Ophthalmic exam if \> 4 weeks therapy QTc for prolongation
27
Isavuconazole coverage
Invasive Aspergillosis Mucormycosis
28
Isavuconazole ADR/DDI
Loading Dose QT shortening Nephrotoxic GI Hypotension Hypo K/Mg Inhibition: CYP3A4, P-glycoprotein, OCT-2
29
Isavuconazole Misc
Best bioavailability Half life 130 Hrs No Renal/Hepatic dosing Administered as Prodrug Isavuconium Monitor LFTs
30
Fluconazole & Itraconazole coverage
**_NO_** C. Glabrata C. Krusei Aspergillus (Fluconazole only) Fusarium Scedosporium Zygomycetes
31
Itraconazole ADR/DDI
99% protein bound Capsule or solution, no change Renal adjustment
32
Itraconazole MISC
Capsules with food Suspension without food
33
Posaconazole Coverage
**_NO_** Scedosporium
34
Posaconazole ADR/DDI
Potent 3A4 Inhibitor Inhibitor & substrate P-glycoprotein GI HA Hepatotoxic (rare) QT Prolongation Hemolytic Uremic Syndrome
35
Posaconazole MISC
Higher oral bioavailability w/food DEC absorption w/ PPIs, H2RA Oral Slow-Onset No renal adjust Monitor: SCr, electrolytes, LFTs
36
Echinocandins
Caspofungin Anidulafungin Micafungin CAM Fungin
37
Echinocandin MoA
Inhibit glucan synthesis in Cell wall -\> cell Wall ruptures Good distribution, poor CNS penetration
38
Echinocandin coverage
Invasive Candidiasis Empiric coverage in netropenic fever (immunocompromised fever) Fungicidal against most Candidiasis spp Fungistatic vs Aspergillus
39
Caspofungin ADR/DDI
CYP inducers reduce dose -\> increase dose Cyclosporin may increase AUC by 35% Reduces tacrolimus (immunosuppressant) levels by 20%
40
Micafungin ADR/DDI
Increases concentration of Sirolimus (anti-transplant rejection drug) Increases AUC and Cmax of nifedipine
41
Anidulafungin ADR/DDI
None
42
Echinocandin MISC
Well tolerated No renal adjust Extensive half-life, once daily dosing 97-99% protein bound
43
Flucytosine Coverage
ALL Candida **EXCEPT** C. Krusei Cryptococcus neoformans Aspergillus sp.
44
Flucytosine MoA
Anti-metabolite (decreases DNA synthesis) Has synergy, usually Co-administered
45
Flucytosine ADR/DDI
Never use alone (resistance develops quickly) Synergy w/ Amphotericin B. NVD Bone Marrow Suppression (dose-dependent avoid other suppressors) Enterocolitis Hepatotoxicity (avoid other nephrotoxic agents)
46
Flucytosine MISC
Admin over 15 min w/food to limit N/V Monitor: CBC/SCr/LFTs and serum levels (especially in pts w/poor renal)